{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:17:01Z","timestamp":1791433021402,"version":"4.3.3"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.clnesp.2024.05.020","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T02:33:48Z","timestamp":1716863628000},"page":"206-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Malnutrition and cachexia are associated with poor CAR T-cell therapy outcomes including survival"],"prefix":"10.1016","volume":"62","author":[{"given":"B.","family":"Cucchiaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.A.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.","family":"Weekes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"O'Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Roddie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Slee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clnesp.2024.05.020_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5045\/br.2019.54.2.81","article-title":"Chimeric antigen T cell receptor treatment in hematological malignancies","volume":"54","author":"Ali","year":"2019","journal-title":"Blood Res"},{"issue":"1","key":"10.1016\/j.clnesp.2024.05.020_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1470-2045(18)30864-7","article-title":"Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial","volume":"20","author":"Locke","year":"2019","journal-title":"Lancet Oncol Jan"},{"issue":"1","key":"10.1016\/j.clnesp.2024.05.020_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa1804980","article-title":"Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma","volume":"380","author":"Schuster","year":"2019","journal-title":"N\u00a0Engl J Med Jan"},{"issue":"7","key":"10.1016\/j.clnesp.2024.05.020_bib4","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa2116133","article-title":"Axicabtagene ciloleucel as second-line therapy for large B-cell lymphoma","volume":"386","author":"Locke","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnesp.2024.05.020_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/2155179018822781","article-title":"Approval of first CAR-Ts: have we solved all hurdles for ATMPs?","volume":"11","author":"Seimetz","year":"2019","journal-title":"Cell Med"},{"issue":"24","key":"10.1016\/j.clnesp.2024.05.020_bib6","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1182\/blood.2022016945","article-title":"Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis","volume":"140","author":"Di Blasi","year":"2022","journal-title":"Blood Dec"},{"issue":"5","key":"10.1016\/j.clnesp.2024.05.020_bib7","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.clnu.2017.06.017","article-title":"ESPEN expert group recommendations for action against cancer-related malnutrition","volume":"36","author":"Arends","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2024.05.020_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fimmu.2021.611366","article-title":"Characteristics and risk factors of cytokine release syndrome in chimeric antigen receptor T cell treatment","volume":"12","author":"Yan","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.clnesp.2024.05.020_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.annonc.2020.10.478","article-title":"Side-effect management of chimeric antigen receptor (CAR) T-cell therapy","volume":"32","author":"Schubert","year":"2021","journal-title":"Ann Oncol Jan"},{"issue":"1","key":"10.1016\/j.clnesp.2024.05.020_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1164\/rccm.201810-1945ED","article-title":"Critical care management of chimeric antigen receptor T cell-related toxicity. Be aware and prepared","volume":"200","author":"Azoulay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"23\u201324","key":"10.1016\/j.clnesp.2024.05.020_bib11","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s00508-021-01948-2","article-title":"CAR T-cell therapy and critical care: a survival guide for medical emergency teams","volume":"133","author":"Messmer","year":"2021","journal-title":"Wien Klin Wochenschr Dec"},{"issue":"5","key":"10.1016\/j.clnesp.2024.05.020_bib12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s11914-022-00746-7","article-title":"Attenuating muscle mass loss in critical illness: the role of nutrition and exercise","volume":"20","author":"Chapple","year":"2022","journal-title":"Curr Osteoporos Rep"},{"issue":"5","key":"10.1016\/j.clnesp.2024.05.020_bib13","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.3390\/ijms24055040","article-title":"Sepsis-associated muscle wasting: a comprehensive review from bench to bedside","volume":"24","author":"Yoshihara","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.clnesp.2024.05.020_bib14","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.bbadis.2016.07.003","article-title":"Dexamethasone-induced muscular atrophy is mediated by functional expression of connexin-based hemichannels","volume":"1862","author":"Cea","year":"2016","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"6","key":"10.1016\/j.clnesp.2024.05.020_bib15","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/jcsm.12224","article-title":"The incidence of sarcopenia among hospitalized older patients: results from the Glisten study","volume":"8","author":"Martone","year":"2017","journal-title":"J\u00a0Cachexia Sarcopenia Muscle Dec"},{"issue":"4","key":"10.1016\/j.clnesp.2024.05.020_bib16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00262-022-03287-1","article-title":"Lymphodepleting chemotherapy practices and effect on safety and efficacy outcomes in patients with solid tumours undergoing T cell receptor-engineered T cell (TCR-T) Therapy: a systematic review and meta-analysis","volume":"72","author":"Owen","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.clnesp.2024.05.020_bib17","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2022009019","article-title":"Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma","author":"Roddie","year":"2023","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.clnesp.2024.05.020_bib18","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.clnu.2019.07.002","article-title":"Clinical utility of the modified Glasgow Prognostic Score to classify cachexia in patients with advanced cancer in palliative care","volume":"39","author":"da Silva","year":"2020","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.clnesp.2024.05.020_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jcsm.12383","article-title":"GLIM criteria for the diagnosis of malnutrition - a consensus report from the global clinical nutrition community","volume":"10","author":"Cederholm","year":"2019","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"6","key":"10.1016\/j.clnesp.2024.05.020_bib20","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1158\/2326-6066.CIR-22-0487","article-title":"Influence of adipose tissue distribution, sarcopenia, and nutritional status on clinical outcomes after CD19 CAR T-cell therapy","volume":"11","author":"Rejeski","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.clnesp.2024.05.020_bib21","series-title":"Obesity: identification, assessment and management (CG189)","first-page":"1","year":"2022"},{"issue":"1","key":"10.1016\/j.clnesp.2024.05.020_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bjh.18054","article-title":"Cachexia is a risk factor for negative clinical and functional outcomes in patients receiving chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma","volume":"197","author":"Roy","year":"2022","journal-title":"Br J Haematol Apr"},{"key":"10.1016\/j.clnesp.2024.05.020_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tipsro.2020.10.001","article-title":"Sarcopenia in cancer: risking more than muscle loss","volume":"16","author":"Anjanappa","year":"2020","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"issue":"8","key":"10.1016\/j.clnesp.2024.05.020_bib24","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/jnci\/djy231","article-title":"Impact of sarcopenia on adverse outcomes after allogeneic hematopoietic cell transplantation","volume":"111","author":"Armenian","year":"2019","journal-title":"JNCI: Journal of the National Cancer Institute"},{"issue":"4","key":"10.1016\/j.clnesp.2024.05.020_bib25","doi-asserted-by":"crossref","first-page":"340.e1","DOI":"10.1016\/j.jtct.2021.01.006","article-title":"Body weight loss before allogeneic hematopoietic stem cell transplantation predicts survival outcomes in acute leukemia patients","volume":"27","author":"Tamaki","year":"2021","journal-title":"Transplant Cell Ther Apr"},{"key":"10.1016\/j.clnesp.2024.05.020_bib26","article-title":"Simple score of albumin and CRP predicts high-grade toxicity in patients with multiple myeloma receiving CAR-T therapy","author":"Akhtar","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.clnesp.2024.05.020_bib27","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00520-019-04952-5","article-title":"The effect of malnutrition on mortality in hospitalized patients with hematologic malignancy","volume":"28","author":"Yilmaz","year":"2020","journal-title":"Support Care Cancer"},{"issue":"17","key":"10.1016\/j.clnesp.2024.05.020_bib28","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.3390\/ijms21176290","article-title":"Effects of IL-6 signaling pathway inhibition on weight and BMI: a systematic review and meta-analysis","volume":"21","author":"Patsalos","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.clnesp.2024.05.020_bib30","first-page":"1","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-Vornhagen","year":"2018","journal-title":"J\u00a0Immunother Cancer Jun"},{"issue":"7","key":"10.1016\/j.clnesp.2024.05.020_bib31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41408-021-00515-2","article-title":"The impact of obesity and body weight on the outcome of patients with relapsed\/refractory large B-cell lymphoma treated with axicabtagene ciloleucel","volume":"11","author":"Wudhikarn","year":"2021","journal-title":"Blood Cancer J Jul"},{"issue":"9","key":"10.1016\/j.clnesp.2024.05.020_bib32","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.3324\/haematol.2021.280189","article-title":"Increased visceral fat distribution and body composition impact cytokine release syndrome onset and severity after CD19 chimeric antigen receptor T-cell therapy in advanced B-cell malignancies","volume":"107","author":"Dos Santos","year":"2022","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.clnesp.2024.05.020_bib33","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.clnu.2021.11.014","article-title":"Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement","volume":"41","author":"Donini","year":"2022","journal-title":"Clin Nutr Apr"},{"key":"10.1016\/j.clnesp.2024.05.020_bib34","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2147\/CMAR.S294105","article-title":"Current screening methods for the risk or presence of malnutrition in cancer patients","volume":"14","author":"Molfino","year":"2022","journal-title":"Cancer Manag Res"},{"issue":"5","key":"10.1016\/j.clnesp.2024.05.020_bib35","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","article-title":"ESPEN practical guideline: clinical Nutrition in cancer","volume":"40","author":"Muscaritoli","year":"2021","journal-title":"Clin Nutr May"},{"issue":"6","key":"10.1016\/j.clnesp.2024.05.020_bib36","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s11912-022-01240-0","article-title":"Rehabilitation needs for patients undergoing CAR T-cell therapy","volume":"24","author":"Obaisi","year":"2022","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.clnesp.2024.05.020_bib37","series-title":"Nutritional status of patients undergoing chimeric antigen receptor T-cell (CAR-T) therapy; a feasibility study [abstract]","author":"Carty","year":"2022"},{"issue":"Apr","key":"10.1016\/j.clnesp.2024.05.020_bib38","article-title":"Current landscape of nutrition within prehabilitation oncology research: a scoping review","volume":"8","author":"Gillis","year":"2021","journal-title":"Front Nutr"},{"issue":"6","key":"10.1016\/j.clnesp.2024.05.020_bib39","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr Dec"},{"issue":"5","key":"10.1016\/j.clnesp.2024.05.020_bib40","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol May"},{"issue":"9","key":"10.1016\/j.clnesp.2024.05.020_bib41","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.clnu.2023.07.011","article-title":"ESPEN practical and partially revised guideline: clinical nutrition in the intensive care unit","volume":"42","author":"Singer","year":"2023","journal-title":"Clin Nutr Sep"},{"issue":"7","key":"10.1016\/j.clnesp.2024.05.020_bib42","first-page":"1065","article-title":"Nutritional risk screening and assessment","volume":"8","author":"Reber","year":"2019","journal-title":"J\u00a0Clin Med"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724001396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724001396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T18:58:48Z","timestamp":1718737128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457724001396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":41,"alternative-id":["S2405457724001396"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.05.020","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malnutrition and cachexia are associated with poor CAR T-cell therapy outcomes including survival","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.","name":"copyright","label":"Copyright"}]}}